These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22934769)

  • 1. Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.
    Hackenhaar FS; Martinez D; Medeiros TM; Klein C; Alabarse PV; Wainstein MV; Gonçalves SC; Benfato MS
    Curr Med Chem; 2012; 19(25):4359-66. PubMed ID: 22934769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
    J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus].
    Wang H; Deng H; Liu W
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):179-82. PubMed ID: 11940319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients.
    Varadhan S; Venkatachalam R; Perumal SM; Ayyamkulamkara SS
    Arch Razi Inst; 2022 Apr; 77(2):853-859. PubMed ID: 36284944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
    Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N
    Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
    Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
    Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.
    Abdallah E; El-Shishtawy S; Sherif N; Ali A; El-Bendary O
    Int Urol Nephrol; 2017 Feb; 49(2):329-335. PubMed ID: 27878751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X.
    Kayikcioglu M; Saygi S; Azarsiz E; Can LH; Kultursay H; Sözmen EY
    Acta Cardiol; 2007 Jun; 62(3):245-9. PubMed ID: 17608098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease.
    Inami T; Seino Y; Otsuka T; Yamamoto M; Kimata N; Murakami D; Takano M; Ohba T; Ibuki C; Mizuno K
    J Cardiol; 2012 Sep; 60(3):180-6. PubMed ID: 22525967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?
    Ertürk C; Altay MA; Bilge A; Çelik H
    Clin Rheumatol; 2017 Dec; 36(12):2775-2780. PubMed ID: 28631083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
    Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
    Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.